Mississauga, ON -- (SBWIRE) -- 03/10/2015 -- AllPennyStocks.com Media, Inc. (http://www.AllPennyStocks.com/) announces its latest article titled "Shares of DIAGNOS Inc. Explode on Agreement for Screening Program for Diabetic Eye Disease."
Companies mentioned in this article include DIAGNOS Inc. (TSX-Venture:ADK).
At AllPennyStocks.com, we frequently write on companies involved in the diabetes space as it is a disease growing worldwide at an unabated fast pace with still only limited treatment options. We're not just delivering a public service announcement (although everyone should get checked and maintain care protocols); we see the area as a tremendous opportunity for companies that can develop effective products. The International Diabetes Federation estimates that a stunning 387 million people have diabetes currently and that number will swell to 592 million in the next twenty years at the current pace.
Of the many frequent concerns that diabetes patients are faced with, eye damage ranks high in prominence. Diabetic eye disease is the broad term covering several eye problems that can cause severe vision loss or blindness as a complication of diabetes, including diabetic retinopathy (damaged blood vessels in the retina), cataracts (clouding of eye lens) and glaucoma (increased fluid pressure in the eye, leads to optic nerve damage). Diabetic retinopathy is the most common diabetic eye disease and a leading cause of blindness in adults.
Brossard, Quebec-based DIAGNOS Inc. (TSX-Venture:ADK) has developed and brought to market the software program CARA (Computer Assisted Retinal Analysis). CARA, a clinically proven tele-ophthalmology platform, uses enhanced digital images to support the early detection of vision loss and more particularly diabetic retinopathy. Accessible via the Internet and EMR compatible, CARA integrates with existing equipment and processes at the point of care and is comprised of image upload, image enhancement automated pre-screening, grading by a specialist, and referral to a specialist, making it possible for high volumes of patients to be screened in real time. The company's screening program can also detect other vision-threatening diseases, such as age-related macular degeneration. In short, CARA detects patients at risk of complications so preventative measures can be implemented to improve the quality of life of diabetes patients and reduce the risk of severe eye damage or blindness.
The full version of this article can be found at:
AllPennyStocks.com is focused on the small-cap / penny stock market and has become a reputable name in the investment community. AllPennyStocks.com runs a Canadian and US site to provide investors in Canada as well as the United States with informative and unique content and information. AllPennyStocks.com runs daily technical penny stocks to watch, has a daily market write-up, provides company spotlights, runs unique most active pages strictly for penny stocks trading on the TSX, TSX Venture, NASDAQ and OTC BB, and much more information for the average investor.
AllPennyStocks.com also runs an email newsletter that aims to uncover stocks that are still under the radar of most investors. Criteria AllPennyStocks.com looks for includes strong revenues, a seasoned management, innovative business plans, among many others. AllPennyStocks.com also looks for companies that announce breaking news, recent 52-week highs/lows, technical breakouts, and other favorable corporate information.
Investors are encouraged to subscribe to the AllPennyStocks.com FREE e-mail newsletter and see what tens of thousands of other investors have already been receiving since 1999. Investors can receive their free newsletter subscription by clicking here: http://www.allpennystocks.com/aps_common/newsletter_free.asp.
AllPennyStocks.com Media, Inc.
Peter Szafranski -- President
Phone: (905) 361-5680
Websites: http://www.allpennystocks.com / http://www.bullishinvestor.com
Note: AllPennyStocks.com has not received compensation for carrying the above-mentioned company; a full disclaimer can be viewed here: http://www.allpennystocks.com/aps_common/disclaimer.asp.